Hamlet BioPharma AB (publ)

NGM:HAMLET B Stock Report

Market Cap: SEK 439.5m

Hamlet BioPharma Dividends and Buybacks

Dividend criteria checks 0/6

Hamlet BioPharma does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-10.6%

Buyback Yield

Total Shareholder Yield-10.6%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Is Hamlet Pharma (NGM:HAMLET B) In A Good Position To Invest In Growth?

Jul 04
Is Hamlet Pharma (NGM:HAMLET B) In A Good Position To Invest In Growth?

Here's Why We're Watching Hamlet Pharma's (NGM:HAMLET B) Cash Burn Situation

Mar 04
Here's Why We're Watching Hamlet Pharma's (NGM:HAMLET B) Cash Burn Situation

We Think Hamlet Pharma (NGM:HAMLET B) Can Afford To Drive Business Growth

Nov 10
We Think Hamlet Pharma (NGM:HAMLET B) Can Afford To Drive Business Growth

We Think Hamlet Pharma (NGM:HAMLET B) Can Easily Afford To Drive Business Growth

Jun 17
We Think Hamlet Pharma (NGM:HAMLET B) Can Easily Afford To Drive Business Growth

Companies Like Hamlet Pharma (NGM:HAMLET B) Are In A Position To Invest In Growth

Oct 12
Companies Like Hamlet Pharma (NGM:HAMLET B) Are In A Position To Invest In Growth

Will Hamlet Pharma (NGM:HAMLET B) Spend Its Cash Wisely?

Mar 17
Will Hamlet Pharma (NGM:HAMLET B) Spend Its Cash Wisely?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if HAMLET B's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HAMLET B's dividend payments have been increasing.


Dividend Yield vs Market

Hamlet BioPharma Dividend Yield vs Market
How does HAMLET B dividend yield compare to the market?
SegmentDividend Yield
Company (HAMLET B)n/a
Market Bottom 25% (SE)1.6%
Market Top 25% (SE)4.9%
Industry Average (Biotechs)1.6%
Analyst forecast (HAMLET B) (up to 3 years)n/a

Notable Dividend: Unable to evaluate HAMLET B's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HAMLET B's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate HAMLET B's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as HAMLET B has not reported any payouts.


Discover strong dividend paying companies